Results 141 to 150 of about 1,825,523 (203)
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use. [PDF]
Duintjer Tebbens RJ +2 more
europepmc +1 more source
Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.
openaire +1 more source
Protective Efficacy of a Monovalent Oral Type 1 Poliovirus Vaccine: A Case-Control Study
BACKGROUND: A high-potency monovalent oral type 1 poliovirus vaccine (mOPV1) was developed in 2005 to tackle persistent poliovirus transmission in the last remaining infected countries. Our aim was to assess the efficacy of this vaccine in India. METHODS:
Jagadish Deshpande +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vaccination with Inactivated Poliovirus Vaccine and Oral Poliovirus Vaccine in Denmark
Clinical Infectious Diseases, 1984In Denmark a polio vaccination program including both inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine ( OPV ) has been in use since 1968. Three injections of IPV are given when the children are five, six, and 15 months of age. Subsequently, three vaccinations with trivalent OPV are administered at the age of three, four, and five years.
H, von Magnus, I, Petersen
openaire +2 more sources
Type 2 Poliovirus Detection After Global Withdrawal of Trivalent Oral Vaccine [PDF]
Background Mass campaigns with oral poliovirus vaccine (OPV) have brought the world close to the eradication of wild poliovirus. However, to complete eradication, OPV must itself be withdrawn to prevent outbreaks of vaccine-derived poliovirus (VDPV ...
Margarita Pons-salort +2 more
exaly +2 more sources

